pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities ( clinical fontaine stages iii and iv ) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy .
C0030899
pentoxifylline
C0011875
diabetic vascular disorders